CBD Research On Multiple Sclerosis

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464806/ 2014
Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3962995/ 2014
Summary of evidence-based guideline: Complementary and alternative medicine in multiple sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170074/ 2014
CANNABIS USE BY INDIVIDUALS WITH MULTIPLE SCLEROSIS: EFFECTS ON SPECIFIC IMMUNE PARAMETERS
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166212/ 2014
association between smoking and cognitive impairment in multiple sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268035/ 2014
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4325203/ 2015
Sativex in the Management of Multiple Sclerosis-Related Spasticity: Role of the Corticospinal Modulation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399771/ 2015
A Randomized Placebo-Controlled Trial of Duloxetine for Central Pain in Multiple Sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4464808/ 2015
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391783/ 2015
Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473732/ 2015
Multiple sclerosis, cannabis, and cognition: A structural MRI study
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507161/ 2015
A Sativex®-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433500/ 2015
Cannabis-induced alterations in brain activation during a test of information processing speed in patients with MS
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4503575/ 2015
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589813/ 2015
Spasticity in multiple sclerosis and role of glatiramer acetate treatment
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581177/ 2015 Autonomic Dysregulation in Multiple Sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460630/ 2015
Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial results
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604175/ 2015
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604696/ 2015 Symptomatic management in multiple sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4710104/ 2016
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013116/ 2016
Efficacy and safety of cannabinoid oromucosal spray for multiple sclerosis spasticity
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887001/ 2016
Symptomatic Management of Multiple Sclerosis–Associated Tremor Among Participants in the NARCOMS Registry
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321205/ 2016
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5502812/ 2016
Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5365386/ 2017
Treatment of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295796/ 2017
The spectrum of psychosis in multiple sclerosis: a clinical case series
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5300172/ 2017
Tai chi for health benefits in patients with multiple sclerosis: A systematic review
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433226/ 2017
A group-delivered self-management program reduces spasticity in people with multiple sclerosis: A randomized, controlled pilot trial
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412277/ 2017
(−)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5538735/ 2017
Sativex in resistant multiple sclerosis spasticity: Discontinuation study in a large population of Italian patients (SA.FE. study)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5468765/ 2017
Cannabis and cognitive functioning in multiple sclerosis: The role of gender
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5481305/ 2017
Cannabis and Multiple Sclerosis—The Way Forward
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487391/ 2017 Cerebellar Dysfunction in Multiple Sclerosis